|Articles|January 1, 1996
Do All Patients Deserve Treatment with Angiotensin Converting Enzyme Inhibitors after Myocardial Infarction? An Argument to Treat only High-Risk Patients
Author(s)Stephen G. Ball, PhD
Advertisement
Articles in this issue
over 29 years ago
Article
Early Angiotensin Converting Enzyme Inhibition in Patients after Myocardial Infarctionover 29 years ago
Article
Cardiovascular Protective Effects of Angiotensin Converting Enzyme Inhibitorsover 29 years ago
Article
Current Trends and Future Prospects in the Pharmacologic Management of HypertensionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- Overcoming Weight Bias in Health Care Systems
September 15th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
2
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
3
Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology
4
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
5